Appili Therapeutics Inc.
APLI.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 129.40K | 492.40K | 220.10K | 69.80K | 456.50K |
| Total Receivables | 1.22M | 555.70K | 1.31M | 866.50K | 834.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 87.40K | 83.40K | 85.30K | 142.10K | 174.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.44M | 1.13M | 1.61M | 1.08M | 1.46M |
|
|
|||||
| Total Current Assets | 1.44M | 1.13M | 1.61M | 1.08M | 1.46M |
| Net Property, Plant & Equipment | 15.50K | 19.00K | 19.60K | 22.30K | 25.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.46M | 1.15M | 1.63M | 1.10M | 1.49M |
|
|
|||||
| Total Accounts Payable | 3.05M | 3.09M | 3.30M | 3.03M | 2.84M |
| Total Accrued Expenses | 27.10K | 19.20K | 9.50K | 55.90K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.28M | 7.11M | 6.72M | 5.40M | 318.10K |
| Total Finance Division Other Current Liabilities | 1.30K | 31.50K | 31.50K | 34.80K | 29.50K |
| Total Other Current Liabilities | 1.30K | 31.50K | 31.50K | 34.80K | 29.50K |
| Total Current Liabilities | 10.36M | 10.26M | 10.06M | 8.52M | 3.19M |
|
|
|||||
| Total Current Liabilities | 10.36M | 10.26M | 10.06M | 8.52M | 3.19M |
| Long-Term Debt | 563.90K | 602.60K | 621.30K | 646.30K | 5.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.93M | 10.86M | 10.68M | 9.17M | 8.94M |
|
|
|||||
| Common Stock & APIC | 39.71M | 41.06M | 40.52M | 40.76M | 41.79M |
| Retained Earnings | -50.00M | -52.87M | -- | -51.02M | -51.48M |
| Treasury Stock & Other | 819.40K | 2.10M | -49.57M | 2.20M | 2.25M |
| Total Common Equity | -9.47M | -9.71M | -9.05M | -8.07M | -7.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.47M | -9.71M | -9.05M | -8.07M | -7.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.47M | -9.71M | -9.05M | -8.07M | -7.44M |
|
|
|||||
